News | Heart Valve Technology | January 27, 2025

Study: Mechanical Valves Offer Better Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger


Jan. 25, 2025—A new study presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for patients aged 60 and younger compared to bioprosthetic valves. The study, leveraging data from the STS Adult Cardiac Surgery Database (ACSD), offers the most comprehensive analysis to date of prosthetic valve outcomes, encompassing over 100,000 patients.

The study addressed a critical question in cardiac surgery: how age and valve type influence outcomes for patients undergoing surgical AVR. It found that patients aged 60 and younger had lower all-cause mortality with mechanical valves.

Key Findings Include:

  • Decline in mechanical valve use: Despite superior outcomes in younger populations, mechanical valve use decreased from 20% to 10% over the study's 12-year period.
  • Survival advantage: Mechanical valves were independently associated with a lower risk of all-cause mortality in patients 60 years or younger.
  • Robust methodology: The study used comprehensive patient-level data from the STS ACSD and the National Death Index, ensuring precise, validated insights.

“The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement,” said Michael Bowdish, MD, lead author of the study and a cardiothoracic surgeon at Cedars-Sinai Medical Center in Los Angeles. “Our research underscores that for patients with an age threshold of 60 years, mechanical valves confer a significant survival advantage. This data will help patients and providers make more informed choices about their care.”

This study also highlights how advancements in surgical techniques and data analytics are improving the ability to tailor treatment plans to individual patients. “By linking the STS database

with the National Death Index, we have a powerful tool to analyze long-term outcomes, paving the way for more personalized and effective care,” Dr. Bowdish added.

The findings are particularly relevant considering the increasing adoption of bioprosthetic surgical valves in many patients and the recent trend of bioprosthetic transcatheter aortic valve replacement (TAVR) in younger populations without clear evidence. The current study challenges this practice trend given this important evidence favoring the durability and survival benefits of mechanical valves in patients aged 60 and younger.

The ACSD is part of the STS National Database, one of the largest and most comprehensive clinical registries with nearly 10 million cardiothoracic procedures performed by 4,300+ surgeons. With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the U.S., the data and outcomes from the STS Database specialty registries provide true national benchmarks for clinical outcomes of cardiothoracic surgery.

A copy of the abstract is available upon request.

About STS

The Society of Thoracic Surgeons is a not-for-profit organization representing over 7,800 surgeons, researchers, and allied healthcare professionals worldwide who are committed to improving outcomes for patients undergoing cardiothoracic surgery.


Related Content

News | Heart Valve Technology

Jan. 6, 2025 — Medtronic plc has announced it received CE (Conformité Européenne) Mark for the Harmony Transcatheter ...

Home January 06, 2025
Home
News | Heart Valve Technology

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid ...

Home September 04, 2024
Home
News | Heart Valve Technology

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

Home June 27, 2024
Home
News | Heart Valve Technology

June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed ...

Home June 21, 2024
Home
News | Heart Valve Technology

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial ...

Home June 10, 2024
Home
News | Heart Valve Technology

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
News | Heart Valve Technology

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
News | Heart Valve Technology

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
News | Heart Valve Technology

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
News | Heart Valve Technology

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
Subscribe Now